GL1X · GenesisL1 explorer

Research workbench

Design, synthesis and biological evaluation of potetent quinoline and pyrroloquinoline ammosamide analogues as inhibitors of quinone reductase 2

Analyse Design, synthesis and biological evaluation of potetent quinoline and… in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
3UXH
Type
protein
Length
460 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Ribosyldihydronicotinamide dehydrogenase [quinone]
EC
1.10.99.2
UniProt
P16083
Ligands
FAD, UXH, ZN
Pockets
2 · best druggability 0.78

Structure

x-ray diffraction · 1 distinct chain · 41% helix, 17% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
A, BRibosyldihydronicotinamide dehydrogenase [quinone] (EC 1.10.99.2)protein23041% helix, 17% strandP16083

Ligands and binding sites

  • FAD · Flavin-adenine dinucleotide · ligand · 2 copies · chains A, B
  • UXH · 6,8-diamino-7-chloro-1-methyl-2-oxo-1,2-dihydropyrrolo[4,3,2-de]quinoline-4-carboxamide · ligand · 2 copies · chains A, B
  • ZN · Zinc ion · metal · 2 copies · chains A, B

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

2 pockets found on a 1 Å grid, 2 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
15350.780.8543UXH, FAD
25920.780.8349FAD, UXH

Interfaces

1 interface between chains.

  • A–B · 2068 Ų buried · 29 hydrogen bonds · protein-protein

Compared structures

  • 3UXH · Design, Synthesis and Biological Evaluation of Potetent Quinoline and Pyrroloquinoline… · the same entry in another collection · chain B against B, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.